Evidence map›Paper›PMID 39003427›Full record

ArticleJournal of neurology2024

Patients with complex and very-early-onset ATL1-related spastic paraplegia offer insights on genotype/phenotype correlations and support for autosomal recessive forms of SPG3A.

Angélique Hamamie-Chaar, Mathilde Renaud, Pinar Gençpinar, Ange-Line Bruel, Christophe Philippe, Julien Maraval, Caroline Racine, Nawale Hadouiri, Laetitia Lambert, Emmanuelle Schmitt and 5 more

Abstract readCase Reports
In one paragraph

Article in Journal of neurology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Angélique Hamamie-ChaarDepartment of Clinical Genetics, Dijon University Hospital, Dijon, France.
Mathilde RenaudDepartment of Clinical Genetics, CHRU Nancy, Nancy, France.
Pinar GençpinarDepartment of Pediatric Neurology, İzmir Katip Çelebi University, Izmir, Turkey.
Ange-Line BruelInserm UMR1231 Team GAD, University of Burgundy and Franche-Comté, Dijon, France.
Christophe PhilippeInserm UMR1231 Team GAD, University of Burgundy and Franche-Comté, Dijon, France.
Julien MaravalDepartment of Clinical Genetics, Dijon University Hospital, Dijon, France.
Caroline RacineDepartment of Clinical Genetics, Dijon University Hospital, Dijon, France.
Nawale HadouiriDepartment of Clinical Genetics, Dijon University Hospital, Dijon, France.
Laetitia LambertDepartment of Clinical Genetics, CHRU Nancy, Nancy, France.
Emmanuelle SchmittINSERM-U1256 NGERE, Université de Lorraine, Nancy, France.
Guillaume BanneauDepartment of Clinical Genetics, CHU Toulouse, Toulouse, France.
Armand HocquelDepartment of Clinical Genetics, CHRU Nancy, Nancy, France.
Christel Thauvin-RobinetDepartment of Clinical Genetics, Dijon University Hospital, Dijon, France.
Laurence Faivre *Department of Clinical Genetics, Dijon University Hospital, Dijon, France.
Quentin Thomas *Department of Clinical Genetics, Dijon University Hospital, Dijon, France. quentin.thomas@chu-dijon.fr.ORCID http://orcid.org/0000-0003-1185-1663

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Spastic paraplegia type 3A (SPG3A) is the second most common form of hereditary spastic paraplegia (HSP). This autosomal-dominant-inherited motor disorder is caused by heterozygous variants in the ATL1 gene which usually presents as a pure childhood-onset spastic paraplegia. Affected individuals present muscle weakness and spasticity in the lower limbs, with symptom onset in the first decade of life. Individuals with SPG3A typically present a slow progression and remain ambulatory throughout their life. Here we report three unrelated individuals presenting with very-early-onset (before 7 months) complex, and severe HSP phenotypes (axial hypotonia, spastic quadriplegia, dystonia, seizures and intellectual disability). For 2 of the 3 patients, these phenotypes led to the initial diagnosis of cerebral palsy (CP). These individuals carried novel ATL1 pathogenic variants (a de novo ATL1 missense p.(Lys406Glu), a homozygous frameshift p.(Arg403Glufs*3) and a homozygous missense variant (p.Tyr367His)). The parents carrying the heterozygous frameshift and missense variants were asymptomatic. Through these observations, we increase the knowledge on genotype-phenotype correlations in SPG3A and offer additional proof for possible autosomal recessive forms of SPG3A, while raising awareness on these exceptional phenotypes. Their ability to mimic CP also implies that genetic testing should be considered for patients with atypical forms of CP, given the implications for genetic counseling.

Indexed as

GTP-Binding ProteinsMembrane ProteinsSpastic Paraplegia, HereditaryAdolescentAdultChildChild, PreschoolFemaleGenetic Association StudiesHumansInfantMalePhenotypeATL1 protein, humanGTP-Binding ProteinsMembrane ProteinsATL1BiallelicEarly-onsetHomozygousLoss-of-functionSpastic paraplegiaSPG3A

Identifiers

PMID39003427
PMCPMC11377504

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.